Research Non-invasive electrical brain stimulation enhances memory in older adults: study The improvements were sustained for at least one month after the experiment Natalia Buendia CalvilloAugust 24, 2022
Cannabis Cannabis and psychedelic use among young people reaches all-time high in 2021: NIH Monitoring the Future panel study supported by the NIH outlines new statistics Rowan DunneAugust 24, 2022
International Mind Medicine Australia receives AUD$1M grant for psychedelic research New fund will support studies on psychedelic-assisted therapies for the treatment of mental health conditions Rowan DunneAugust 23, 2022
Cannabis Tilray receives approval for CBD oral solution in Australia and New Zealand Flagship product from company's medical cannabis division now set for clinical trial use Rowan DunneAugust 23, 2022
Canada PharmAla Biotech becomes first public company producing GMP MDMA Biotechnology organization will also supply LaNeo product to Australian research institute for clinical trial Rowan DunneAugust 22, 2022
Research ‘Hallucinogen’ use continues to rise: Columbia University New research estimates that over 5.5 million American adults used psychoactive substances in 2019 Rowan DunneAugust 22, 2022
Research Better sleep quality calls for better data: Yam and Goettling Better follow up is also a necessity, and wearable sleep trackers are only the beginning Rowan DunneAugust 19, 2022
Cannabis Jointly releases data showcasing cannabis health benefits New statistics come from over 200,000 unique experiences cannabis users have recorded on the company platform Rowan DunneAugust 18, 2022
Business Pure Sunfarms extends pot research partnership with Simon Fraser University The partnership started in 2018 Natalia Buendia CalvilloAugust 17, 2022
Canada Optimi receives amendment from Health Canada permitting MDMA production Vancouver producer to supply synthetic psychedelic compounds to designated investigators and companies Rowan DunneAugust 16, 2022